• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login

    Investing News NetworkYour trusted source for investing success

    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    AbbVie Declares Quarterly Dividend

    Investing News Network
    Feb. 17, 2021 11:58PM PST
    Biotech Investing
    The board of directors of ABBVie Inc. today declared a quarterly cash dividend of $1.30 per share. The cash dividend is payable May 14, 2021 to stockholders of record at the close of business on April 15, 2021 . Since the company's inception in 2013, AbbVie has increased its dividend by 225 percent.  AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their ...
     
     

    The board of directors of ABBVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.30 per share.

     

    The cash dividend is payable May 14, 2021 to stockholders of record at the close of business on April 15, 2021 .

     

    Since the company's inception in 2013, AbbVie has increased its dividend by 225 percent.  AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.

     

      About AbbVie  

     

    AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on Twitter , Facebook , Instagram , YouTube and LinkedIn .

     

     

     

     Cision View original content: https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-301231095.html  

     

    SOURCE AbbVie

     
     

    News Provided by PR Newswire via QuoteMedia

    The Conversation (0)

    Latest News

    RAD receives IND approval from US FDA for Betabart (RV-01)

    Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Biotech Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×